Parcourir et rechercher des captures

Document d'orientation sur les rappels d'instruments médicaux (GUI-0054) : Registres de distribution Aperçu Définition d'un rappel, processus documentés Registres de distribution Processus de rappel Rapports sur les rappels et processus de rappel Dossiers de rappel Rapports sur…

Archived List of non-prescription drugs for which the testing requirements set out in subsections C.02.019 (1) and (2) of the Food and Drug Regulations do not apply Links to previous versions of the lists are provided below for information and reference purposes. For the most…

COVID-19 guidance for reporting medical device shortages: Definitions, interpretation and acronyms Background Who must report What must be reported When and how to report What happens to your report Definitions and interpretation Health Canada has made the medical device shortage…

COVID-19 guidance for reporting medical device shortages: What happens to your report Background Who must report What must be reported When and how to report What happens to your report Definitions and interpretation Health Canada has made the medical device shortage reporting…

COVID-19 guidance for reporting medical device shortages: When and how to report Background Who must report What must be reported When and how to report What happens to your report Definitions and interpretation Health Canada has made the medical device shortage reporting…

COVID-19 guidance for reporting medical device shortages: What must be reported Background Who must report What must be reported When and how to report What happens to your report Definitions and interpretation Health Canada has made the medical device shortage reporting…

Annex 1 to the Good manufacturing practices guide - Manufacture of sterile drugs (GUI-0119) - Summary Overview Principle, pharmaceutical quality system Premises, equipment, utilities and personnel Production and specific technologies Environmental and process monitoring Quality…

Report of the Expert Advisory Panel on Prochymal® January 26, 2012 The Expert Advisory Panel on Prochymal ® was convened at the request of the Biologics and Genetic Therapies Directorate (BGTD), Health Canada. The panel's mandate was to provide advice to BGTD on the benefits and…

Summary of Expertise, Experience, Affiliations and Interests: Expert Advisory Panel on the use of Avastin in Metastatic Breast Cancer (EAP-AmBC) - Health Canada (PDF Version - 50 K) Purpose The following table summarizes the information about expertise, experience, and…

Terms of Reference: Expert Advisory Panel on the use of Avastin in Metastatic Breast Cancer (EAP-AmBC) - Health Canada The Biologics and Genetic Therapies Directorate's (BGTD) Expert Advisory Panel on the Use of AVASTIN™ in Metastatic Breast Cancer (EAP-AmBC) is being established…